Cannara Biotech Inc.
LOVE.V
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.60% | -9.91% | 6.93% | 74.14% | 204.71% |
| Total Depreciation and Amortization | 15.68% | 27.19% | 22.49% | 21.72% | 19.86% |
| Total Amortization of Deferred Charges | -10.71% | -23.23% | 131.61% | 131.61% | 37.00% |
| Total Other Non-Cash Items | 333.53% | 145.76% | 1,269.04% | 1,153.06% | 73.93% |
| Change in Net Operating Assets | 123.42% | 58.34% | 59.78% | 45.50% | 41.37% |
| Cash from Operations | 134.66% | 91.24% | 1,541.38% | 269.42% | 196.49% |
| Capital Expenditure | 33.47% | 25.15% | 33.41% | 39.29% | 46.01% |
| Sale of Property, Plant, and Equipment | 1,080.82% | 994.43% | 2,591.91% | 24.55% | 256.10% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.64% | -23.32% | -10.78% | -8.15% | 53.99% |
| Cash from Investing | 57.40% | 45.77% | 50.48% | 40.16% | 47.68% |
| Total Debt Issued | -32.73% | 90.00% | -82.36% | -83.70% | -86.21% |
| Total Debt Repaid | -115.95% | -107.99% | 80.43% | 90.59% | 90.36% |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | 99.34% | 25.99% | -180.99% | -2,094.01% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.71% | 8.47% | -27.49% | -76.94% | -98.68% |
| Cash from Financing | -95.38% | 19.05% | -117.79% | -111.06% | -114.50% |
| Foreign Exchange rate Adjustments | -- | -- | 100.00% | 100.42% | 87.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 283.40% | 129.71% | 171.46% | 75.43% | 46.35% |